Integrating proteomics and transcriptomics for systematic combinatorial chimeric antigen receptor therapy of AML Journal Article
| Authors: | Perna, F.; Berman, S. H.; Soni, R. K.; Mansilla-Soto, J.; Eyquem, J.; Hamieh, M.; Hendrickson, R. C.; Brennan, C. W.; Sadelain, M. |
| Article Title: | Integrating proteomics and transcriptomics for systematic combinatorial chimeric antigen receptor therapy of AML |
| Abstract: | Chimeric antigen receptor (CAR) therapy targeting CD19 has yielded remarkable outcomes in patients with acute lymphoblastic leukemia. To identify potential CAR targets in acute myeloid leukemia (AML), we probed the AML surfaceome for overexpressed molecules with tolerable systemic expression. We integrated large transcriptomics and proteomics datasets from malignant and normal tissues, and developed an algorithm to identify potential targets expressed in leukemia stem cells, but not in normal CD34+CD38− hematopoietic cells, T cells, or vital tissues. As these investigations did not uncover candidate targets with a profile as favorable as CD19, we developed a generalizable combinatorial targeting strategy fulfilling stringent efficacy and safety criteria. Our findings indicate that several target pairings hold great promise for CAR therapy of AML. Perna et al. search for optimal chimeric antigen receptor targets in acute myeloid leukemia using extensive proteomics and transcriptomics. In the absence of a target as favorable as CD19, they develop a generalizable combinatorial targeting strategy identifying several promising target pairings. © 2017 Elsevier Inc. |
| Keywords: | controlled study; leukemia; human cell; leukemia, myeloid, acute; t lymphocyte; t-lymphocytes; metabolism; cd34 antigen; gene expression; gene expression profiling; protein targeting; cell line, tumor; proteomics; transcriptomics; cancer therapy; immunology; hybrid protein; immunotherapy; recombinant fusion proteins; receptors, antigen, t-cell; algorithm; tumor cell line; hematopoietic cell; chimeric antigen receptor; myeloid progenitor cell; cd19 antigen; lymphocyte antigen receptor; antigens, cd19; cd38 antigen; acute myeloid leukemia (aml); acute myeloid leukemia; procedures; high-throughput annotation; humans; human; priority journal; article; car t cell; combinatorial strategies; surfaceome; target discovery |
| Journal Title: | Cancer Cell |
| Volume: | 32 |
| Issue: | 4 |
| ISSN: | 1535-6108 |
| Publisher: | Cell Press |
| Date Published: | 2017-10-09 |
| Start Page: | 506 |
| End Page: | 519.e5 |
| Language: | English |
| DOI: | 10.1016/j.ccell.2017.09.004 |
| PUBMED: | 29017060 |
| PROVIDER: | scopus |
| PMCID: | PMC7025434 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 4 December 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work